Sumitomo Pharma, Sumitovant Biopharma, And Myovant Sciences Enter Into Definitive Agreement

Sumitomo Pharma

24/10/2022 04:36

Oct 24 (Reuters) - Sumitomo Pharma Co Ltd  4506.T :
    * SUMITOMO PHARMA CO LTD:  SUMITOMO PHARMA, SUMITOVANT
BIOPHARMA,
AND MYOVANT SCIENCES ENTER INTO DEFINITIVE AGREEMENT
    * SUMITOMO PHARMA CO LTD: SUMITOVANT WILL ACQUIRE ALL
OUTSTANDING
SHARES OF MYOVANT NOT ALREADY OWNED BY SUMITOVANT FOR $27.00 PER
SHARE IN CASH
    * SUMITOMO PHARMA CO LTD: THIS CORRESPONDS TO A TOTAL
TRANSACTION
VALUE OF $1.7 BILLION ON A FULLY DILUTED BASIS, AND A TOTAL
COMPANY VALUE OF $2.9 BILLION ON A FULLY DILUTED BASIS

Source text for Eikon:  ID:nTSvx85c9d 
Further company coverage:  4506.T  MYOV.N 
 (Reporting by Tokyo Newsroom)
 ((+81345201189;))